Dry Eye

According to Mile Brujic, OD, FAAO, low-level light therapy (LLLT) and intense pulsed light have demonstrated tremendous benefits for his patients.

Inside the role of blepharitis in ocular surface disease and effective management strategies.

All 6 biomarkers in the study demonstrated improvement with the treatment of lifitegrast, according to Thimons.

The study found that the prosthetic replacement of the ocular surface ecosystem lenses were well tolerated in the delivery of non-preserved cyclosporine 0.05%.

In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.

The retrospective study investigated and analyzed the severity and frequency of ocular pain and factors affecting it among DED patients living in high altitudes above 2500 meters during the COVID-19 pandemic.

The dry eye drug has been assigned a PDUFA decision date of April 2, 2025, and the Aldeyra has chosen to expand their exclusive option agreement with AbbVie.

What we know and what we do not know…yet.

The lipid-containing lubricating drop established noninferiority in comfort when compared to non-lipid drops, and the lipid-containing group also exhibited statistically significant improvements in visual quality at both day 7 and day 30, highlighting the potential benefits of this formulation for patients.

New research sheds light on how the dry eye medication lifitegrast works beyond the ocular surface, targeting the underlying immune system to provide relief for patients.

Dr. Shane Kannarr discusses findings on perfluorohexyloctane at the Tear Film and Ocular Surface conference, highlighting its rapid symptom relief and enhanced patient satisfaction.

Higher prevalence rates were also found among university students and administrative workers.

Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes, investigators reported at the 2024 American Academy of Ophthalmology meeting.

There’s more to dry eye treatment than eye drops.

MeiboMetrics is scheduled to be available on several platforms starting in 2025.

Reproxalap was previously found to be statistically superior to vehicle for the primary endpoint of ocular discomfort (P=0.004) in a Phase 3 randomized, double-masked, vehicle-controlled dry eye chamber clinical trial.

Choosing the best lens is a puzzle that requires consideration of all the pieces.

Sabrina Gaan, OD, shares some of her most-used devices in her dry eye clinic and what helped her most in growing her specialized care.

The FDA and Palatin agreed on a clear regulatory path for PL9643 NDA submission in DED. The company hopes to start patient enrollment to start in the fourth quarter of calendar year 2024.

Understanding the latest innovative technologies.

Actionable tips to improve comfort and fit.

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO, weigh in on meibomian gland dysfunction and dry eye disease what to consider when choosing symptom management options.

The survey’s results were released by Bausch + Lomb last month and revealed that many participants did not know their symptoms were dry eye-related.